Food Allergy & Asthma News Videos

PIX11 News (Dec 2025)

NYC Council Passes Bill Mandating Schools & Daycare Carry EpiPens

PIX11 reports on the New York City Council's unanimous passage of Int 895, sponsored by Speaker Julie Menin, requiring all public schools and daycare centers to stock epinephrine auto-injectors — honoring the legacy of Elijah Silvera.

NYC City Council (2025)

Speaker Julie Menin Joins Council Members to Discuss Stated Meeting

NYC Council Speaker Julie Menin — sponsor of Int 895 — joins council members to discuss the stated meeting where the stock epinephrine bill for schools and childcare was advanced, part of the city's Elijah's Law implementation.

Local News (2025)

New Law Raises Awareness After Mom's Fight — Sergio Lopez Allergy Awareness Act

The Sergio Lopez Allergy Awareness Act takes effect September 1, 2025, requiring higher awareness and readiness around food allergies in schools and public spaces — passed after a mother's fight for her late son.

News Coverage (2025)

Epinephrine Auto-Injectors in Day Care Centers

Coverage of Pennsylvania legislation requiring epinephrine auto-injectors in day care facilities, protecting children with life-threatening food allergies in early childhood settings.

Illinois News (2025)

Bill Creating Dillon's Law in Illinois Introduced in State Capitol

News coverage of Illinois HB 2462 — Dillon's Law — which allows trained community members to carry and administer epinephrine auto-injectors for severe allergic reactions. Named after Dillon Mueller, a Wisconsin teen who died from a bee sting in 2014.

Talking Point (2025)

'Do It for Dillon' — Anaphylaxis & Epinephrine Training Program

Mayor Mike Wiza and guests discuss the Dillon Mueller Memorial Fund's 'Do It for Dillon' free epinephrine training program, enabling everyday citizens to recognize anaphylaxis and administer life-saving epinephrine.

Industry Analysis (2026)

SB 68 Explained: California's ADDE Act — Restaurant Allergen Labeling Law

California's SB 68, the Allergen Disclosure for Dining Experiences (ADDE) Act, takes effect July 1, 2026 — requiring restaurant chains with 20+ locations to disclose the Top 9 food allergens on menus. Signed into law October 2025 after unanimous legislative passage.

U.S. FDA (2026)

FDA Public Meeting on Food Allergen Thresholds (Feb 2026)

The FDA hosts a virtual public meeting on food allergen thresholds and their potential applications — a landmark federal engagement on allergen safety policy held February 18, 2026.

Clean Air Task Force (2025)

Community Health Impacts of Air Pollution in the U.S.

Overview of how air pollution and the Clean Air Act directly impact asthma rates and respiratory health in U.S. communities — with 2025 state climate policy wins and trends.

Asthma Advocacy (2025)

Clean Air and Our Lung Health

Anna Marie Bourke, Senior Advocacy and Policy Coordinator, discusses the link between air quality and respiratory health, asthma policy, and what advocates can push for in their communities.

European Lung Foundation (2026)

Breathe Clean Air Patient Conference 2026: Indoor Air Pollution

The 2026 Breathe Clean Air Patient Conference addresses indoor air pollution, its impact on asthma and respiratory disease, and policy solutions for healthier indoor environments.

American Lung Association (2025)

Stock Asthma Medication in Schools: Effective Implementation

The American Lung Association explores stock asthma medication in schools guidance documents — helping schools keep rescue inhalers on hand and reduce the 10–14 million school days lost to asthma each year.

Health News (2025)

Wildfire Smoke Endangers Children with Asthma

Dr. Nicole Johnson explains how wildfire smoke disproportionately harms children with asthma and what families, schools, and policymakers can do to protect vulnerable lungs during smoke events.

News Coverage (2026)

New Report: Nearly 50% of American Children Breathing Unhealthy Air

Dr. Vin Gupta breaks down a new report showing 46% of U.S. children breathe unhealthy air every day — driving asthma rates and underscoring the need for stronger clean air policy.

Asthma Advocacy (2026)

World Asthma Day 2026: Inhaler Access for Everyone

World Asthma Day 2026 spotlights GINA's theme of access to anti-inflammatory inhalers for everyone with asthma — covering the Safe Step Act (H.R. 5509 / S. 2903) and federal investment in asthma care.

News Coverage (2025)

New Peanut Allergy Treatment Could Save Toddlers' Lives

Researchers announce a breakthrough therapy for children ages one to three with peanut allergies — a patch that delivers controlled allergen exposure and could save lives.

CNN 10

Groundbreaking Study Led to Allergy Breakthrough

CNN reports on a landmark study that helped drastically reduce the occurrence of peanut allergies in children — a major advance in food allergy prevention through early introduction.

Documentary (2025)

Retraining the Body to Lift the Life Sentence of Food Allergies

Award-winning documentary exploring how scientists are retraining the immune system to lift the "life sentence" of food allergies through oral immunotherapy and emerging treatments.

Northwestern Medicine Breakthroughs Podcast

Why Are Food Allergies on the Rise? — Dr. Ruchi Gupta

Dr. Ruchi Gupta, MD, MPH — founding director of the Center for Food Allergy and Asthma Research (CFAAR) at Northwestern — breaks down the latest evidence on why childhood and adult food allergies are increasing, and what research tells us about prevention.

CFAAR / Academic Conference

Environmental Factors Contributing to the Food Allergy Epidemic — Dr. Ruchi Gupta

Dr. Ruchi Gupta presents research on environmental contributors to the food allergy epidemic — from the microbiome to dual-allergen exposure — drawing on CFAAR's landmark prevalence studies.

News Coverage (Feb 2024)

FDA Expands Use of Xolair (Omalizumab) to Treat Severe Food Allergies

Coverage of the FDA approval of Xolair (omalizumab) — the first medication approved to reduce allergic reactions, including anaphylaxis, from accidental exposure to multiple foods. A milestone in food allergy biotech treatment.

AAAAI / WAO 2025

Omalizumab Outshines Oral Immunotherapy in Multi-Food Allergy Treatment

New findings from the 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Congress showing omalizumab (Xolair) outperforming oral immunotherapy alone for multi-food allergy treatment.

ATS 2026 Conference

Asthma Biologics: Tezepelumab, Dupilumab & OCS Reduction

Leading asthma specialists at the 2026 American Thoracic Society International Conference discuss new comparative findings on biologics (tezepelumab vs. dupilumab) for severe asthma and reducing oral corticosteroid dependence.

FARE Living Teal Global Summit

Addressing Racial Gaps in Food Allergy Research

FARE's Living Teal Global Summit panel on addressing racial disparities in food allergy research, diagnosis, and access to care — highlighting the need for equitable research participation and treatment access.

Food Allergy Education

Ask the Allergist — Dr. Michael Pistiner

Dr. Michael Pistiner, MD, MMSc — Director of Food Allergy Advocacy, Education and Prevention at Mass General Hospital for Children — answers community questions on food allergy management, prevention, and school preparedness.

News Coverage (2025)

Experimental Food Allergy Therapy Gives New Hope to Sufferers

Coverage of an experimental oral immunotherapy clinical trial confronting food allergy dangers head-on — part of a wider surge of biotech investment in developing food allergy treatments.